Ciprofloxacin for the treatment of Cardiobacterium hominis prosthetic valve endocarditis

Authors

Lisa M. Avery, St. John Fisher UniversityFollow
Catherine B. Felberbaum, Unity Hospital
Muhammad Hasan, St. Joseph's Health

Document Type

Article

Publication Date

2-6-2018

Abstract

Prosthetic valve endocarditis due to Cardiobacterium hominis is rare and recommended therapy includes a third generation cephalosporin. We report a case of Cardiobacterium hominis endocarditis post transcatheter aortic valve replacement in a patient with significant beta-lactam antimicrobial sensitivities who was successfully treated with ciprofloxacin monotherapy in conjunction with surgery.

DOI

10.1016/j.idcr.2018.01.016

Comments

This open access article is also available through the publisher: https://doi.org/10.1016/j.idcr.2018.01.016

Publication Information

Avery, Lisa M.; Felberbaum, Catherine B.; and Hasan, Muhammad (2018). "Ciprofloxacin for the treatment of Cardiobacterium hominis prosthetic valve endocarditis." ID Cases 11, 77-79.

Please note that the Publication Information provides general citation information and may not be appropriate for your discipline. To receive help in creating a citation based on your discipline, please visit http://libguides.sjfc.edu/citations.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.